These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 34453703)
21. Japan's Special Approval for Emergency System During the COVID-19 Pandemic. Maeda H Clin Pharmacol Ther; 2022 Mar; 111(3):551-558. PubMed ID: 34032279 [TBL] [Abstract][Full Text] [Related]
22. Tozinameran (BNT162b2) Vaccine: The Journey from Preclinical Research to Clinical Trials and Authorization. Khehra N; Padda I; Jaferi U; Atwal H; Narain S; Parmar MS AAPS PharmSciTech; 2021 Jun; 22(5):172. PubMed ID: 34100150 [TBL] [Abstract][Full Text] [Related]
23. Emergency Use Authorizations of COVID-19-Related Medical Products. Moshkovits I; Shepshelovich D JAMA Intern Med; 2022 Feb; 182(2):228-229. PubMed ID: 34928303 [TBL] [Abstract][Full Text] [Related]
24. FDA authorizes Moderna COVID-19 vaccine. Med Lett Drugs Ther; 2021 Jan; 63(1616):9-10. PubMed ID: 33512345 [No Abstract] [Full Text] [Related]
25. Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations. Krause PR; Gruber MF N Engl J Med; 2020 Nov; 383(19):e107. PubMed ID: 33064383 [No Abstract] [Full Text] [Related]
26. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021. Dooling K; Gargano JW; Moulia D; Wallace M; Rosenblum HG; Blain AE; Hadler SC; Plumb ID; Moline H; Gerstein J; Collins JP; Godfrey M; Campos-Outcalt D; Morgan RL; Brooks O; Talbot HK; Lee GM; Daley MF; Oliver SE MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1344-1348. PubMed ID: 34555007 [TBL] [Abstract][Full Text] [Related]
27. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021. Woodworth KR; Moulia D; Collins JP; Hadler SC; Jones JM; Reddy SC; Chamberland M; Campos-Outcalt D; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley MF; Mbaeyi S; Dooling K; Oliver SE MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(45):1579-1583. PubMed ID: 34758012 [TBL] [Abstract][Full Text] [Related]
29. Emergency Use Authorizations (EUAs) Versus FDA Approval: Implications for COVID-19 and Public Health. Zuckerman DM Am J Public Health; 2021 Jun; 111(6):1065-1069. PubMed ID: 33950730 [No Abstract] [Full Text] [Related]
30. [COVID-19: Warp Speed vaccines]. Feraoun Y; Maisonnasse P; Le Grand R; Beignon AS Med Sci (Paris); 2021; 37(8-9):759-772. PubMed ID: 34080537 [TBL] [Abstract][Full Text] [Related]
31. Emergency Use Authorization of COVID-19 Vaccine: Implications for Worker Communities. Culp K; Dukes KC; Cowin C; Sinnwell E Workplace Health Saf; 2021 Apr; 69(4):152-153. PubMed ID: 33787400 [No Abstract] [Full Text] [Related]
32. Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems. Saint-Raymond A; Sato J; Kishioka Y; Teixeira T; Hasslboeck C; Kweder SL Expert Rev Clin Pharmacol; 2020 Oct; 13(10):1095-1101. PubMed ID: 32909843 [TBL] [Abstract][Full Text] [Related]
33. Vaccine safety - is the SARS-CoV-2 vaccine any different? Tau N; Yahav D; Shepshelovich D Hum Vaccin Immunother; 2021 May; 17(5):1322-1325. PubMed ID: 33270474 [TBL] [Abstract][Full Text] [Related]
34. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020. Oliver SE; Gargano JW; Marin M; Wallace M; Curran KG; Chamberland M; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1922-1924. PubMed ID: 33332292 [TBL] [Abstract][Full Text] [Related]
35. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021. Hause AM; Baggs J; Gee J; Marquez P; Myers TR; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1379-1384. PubMed ID: 34591835 [TBL] [Abstract][Full Text] [Related]
36. COVID-19 vaccines: concerns beyond protective efficacy and safety. Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347 [TBL] [Abstract][Full Text] [Related]
37. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021. Wallace M; Woodworth KR; Gargano JW; Scobie HM; Blain AE; Moulia D; Chamberland M; Reisman N; Hadler SC; MacNeil JR; Campos-Outcalt D; Morgan RL; Daley MF; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE MMWR Morb Mortal Wkly Rep; 2021 May; 70(20):749-752. PubMed ID: 34014913 [TBL] [Abstract][Full Text] [Related]
38. RxLegal: Emergency Use Authorizations. Gabay M; Vora N Hosp Pharm; 2023 Feb; 58(1):16-17. PubMed ID: 36644751 [TBL] [Abstract][Full Text] [Related]
39. The problem is obtaining knowledge: a qualitative analysis of provider barriers and accelerators to rapid adoption of new treatment in a public health emergency. Williams SH; McFarlane MD; Giammarino M; Oleksa J BMC Public Health; 2023 Jan; 23(1):183. PubMed ID: 36707792 [TBL] [Abstract][Full Text] [Related]
40. The Advisory Committee on Immunization Practices' Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020. McClung N; Chamberland M; Kinlaw K; Bowen Matthew D; Wallace M; Bell BP; Lee GM; Talbot HK; Romero JR; Oliver SE; Dooling K MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(47):1782-1786. PubMed ID: 33237895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]